HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$1.35
Day range
$1.32 - $1.39
Year range
$0.62 - $2.50
Market cap
22.79M USD
Avg Volume
219.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.16M | -27.75% |
Net income | -7.10M | 28.19% |
Net profit margin | — | — |
Earnings per share | -0.38 | 34.48% |
EBITDA | -6.16M | 23.94% |
Effective tax rate | -0.68% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.21M | -64.85% |
Total assets | 19.62M | -66.23% |
Total liabilities | 25.78M | -34.19% |
Total equity | -6.15M | — |
Shares outstanding | 16.55M | — |
Price to book | -3.64 | — |
Return on assets | -67.16% | — |
Return on capital | -112.01% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -7.10M | 28.19% |
Cash from operations | -13.08M | -36.42% |
Cash from investing | 7.21M | 41.23% |
Cash from financing | 7.22M | 2,971.06% |
Net change in cash | 1.32M | 130.93% |
Free cash flow | -10.55M | -69.24% |
About
Founded
2015
Website
Employees
14